First-gen mRNA flu vaccines 'will not win,' Sanofi execs admit as they retool strategy - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on June 30, 2023 at 1:10 PM in business No comments 49
UPDATE: Lilly's next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on June 27, 2023 at 12:45 AM in business No comments 38
Apogee takes aim at Regeneron, Lilly as inflammation-focused biotech readies IPO - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on June 23, 2023 at 10:17 AM in business No comments 38